Literature DB >> 14657753

Phagocytic efficiency of monocytes and macrophages obtained from Sydney blood bank cohort members infected with an attenuated strain of HIV-1.

Katherine Kedzierska1, Melissa Churchill, Clare L V Maslin, Rula Azzam, Philip Ellery, Hiu-Tat Chan, John Wilson, Nicholas J Deacon, Anthony Jaworowski, Suzanne M Crowe.   

Abstract

Defective function of monocyte-derived macrophages contributes to HIV-1 pathogenesis. We found that phagocytosis of the opportunistic pathogens Mycobacterium avium complex and Toxoplasma gondii was impaired in monocytes obtained from individuals infected with wild-type strains of HIV-1 but generally not in monocytes collected over a 6-year period from Sydney Blood Bank Cohort (SBBC) members infected with nef/long terminal repeats (LTR) region-defective strains of HIV-1. However, longitudinal analysis of phagocytosis in 1 SBBC member, C54, showed the development of defective engulfment of opportunistic pathogens at the most recent time points, coincident with the development of further molecular deletions in the nef/LTR region. Another SBBC member, C98, underwent bronchoscopy, which provided material to examine phagocytic signaling in alveolar macrophages. In contrast to normal phagocytic efficiency of C98's monocytes (over a 6-year period), defective signaling events during FcgammaR-mediated phagocytosis by C98's alveolar macrophages were observed. High basal phosphorylation within HIV-infected macrophages correlated with colocalization of tyrosine-phosphorylated proteins with HIV-1 p24 antigen rather than around the phagocytic targets as observed in uninfected cells. Thus, although phagocytic efficiency appears to be generally unimpaired in monocytes from SBBC members, evidence of impairment in recent samples from 1 SBBC member, coincident with further genetic changes within the virus, and abnormal phagocytic signaling in alveolar macrophages from another SBBC member may herald loss of attenuation of those strains.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14657753     DOI: 10.1097/00126334-200312150-00001

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  5 in total

1.  Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.

Authors:  Ronald J Messer; Ulf Dittmer; Karin E Peterson; Kim J Hasenkrug
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-05       Impact factor: 11.205

2.  Impaired phagocytosis among patients infected by the human immunodeficiency virus: implication for a role of highly active anti-retroviral therapy.

Authors:  C Michailidis; G Giannopoulos; V Vigklis; K Armenis; A Tsakris; P Gargalianos
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 3.  Phagocytic activity in human immunodeficiency virus type 1 infection.

Authors:  Agostino Pugliese; Valerio Vidotto; Tiziana Beltramo; Donato Torre
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

4.  Differential effects of gram-positive and gram-negative bacterial products on morphine induced inhibition of phagocytosis.

Authors:  Jana Ninkovic; Ninkovic Jana; Vidhu Anand; Anand Vidhu; Raini Dutta; Dutta Raini; Li Zhang; Anuj Saluja; Jingjing Meng; Lisa Koodie; Koodie Lisa; Santanu Banerjee; Banerjee Santanu; Sabita Roy; Roy Sabita
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

5.  Genomic Analysis of Salmonella enterica Serovar Typhimurium Characterizes Strain Diversity for Recent U.S. Salmonellosis Cases and Identifies Mutations Linked to Loss of Fitness under Nitrosative and Oxidative Stress.

Authors:  Hillary S Hayden; Susana Matamouros; Kyle R Hager; Mitchell J Brittnacher; Laurence Rohmer; Matthew C Radey; Eli J Weiss; Katie B Kim; Michael A Jacobs; Elizabeth H Sims-Day; Min Yue; Mussaret B Zaidi; Dieter M Schifferli; Shannon D Manning; Judd L Walson; Samuel I Miller
Journal:  MBio       Date:  2016-03-08       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.